Eisai Refocuses AiM As It Builds US Immuno-Dementia Research

 
• By Ian Haydock

Amid multiple industry drug failures in the sector, Eisai is opening a new US research facility to discover innovative therapies for dementia based on a long-standing immunology hypothesis.

genetic reasearch
EISAI INVESTIGATES IMMUNO APPROACH TO DEMENTIA • Source: Shutterstock

More from Neurological

More from Therapy Areas